Medicine Man Technologies, Inc.

SHWZ

Medicine Man Technologies, Inc.

SHWZ

Insider Sentiment (TTM):

Last Purchase:2024-04-11Last Sale:-Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2024-03-31Institutional Shares Owned:281,734Shares Outstanding:64,535,245Institutional Ownership Pct.:0.44%

Earnings Market Reaction:

Filing Date:2024-03-27Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31
Assets
Cash And Cash Equivalents At Carrying Value	19	20	20	35	39	39	34	48	106	21	21	23	1
Accounts Receivable Net Current	4	5	6	5	4	5	6	4	4	4	3	2	1
Inventory Net	26	33	34	26	23	21	19	16	11	11	9	6	3
Accounts Receivable Related Parties Current	-	-	-	-	-	-	-	-	0	0	0	0	0
Assets Current
Assets Current	54	64	67	74	72	72	67	71	124	38	36	32	6
Notes And Loans Receivable Net Current	-	-	-	-	0	0	0	0	0	0	0	-	0
Marketable Securities Current	0	0	0	0	0	0	-	-	0	-	-	-	-
Notes Receivable Related Parties Current	-	-	-	-	-	-	-	-	0	0	0	0	0
Other Prepaid Expense Current	-	-	-	-	-	-	-	-	-	-	-	-	1
Prepaid Expense And Other Assets Current	4	6	6	8	5	6	8	3	3	3	-	-	1
Prepaid Expense Current	-	-	-	-	-	-	-	-	-	-	2	1	-
Property Plant And Equipment Net	31	32	31	29	27	26	21	17	10	9	3	3	3
Long Term Investments	2	2	2	2	2	-	-	-	-	-	-	-	-
Disposal Group Including Discontinued Operation As…	0	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	67	77	76	64	95	100	108	119	43	42	42	41	53
Finite Lived Intangible Assets Net	-	-	-	-	-	-	105	95	98	98	95	98	3
Assets Noncurrent
Assets Noncurrent	304	306	302	249	251	258	251	247	161	157	148	149	65
Marketable Securities Noncurrent	-	-	-	-	-	-	0	0	0	0	0	0	0
Intangible Assets Net Excluding Goodwill	166	169	169	132	108	111	-	-	98	-	-	-	-
Nontrade Receivables Noncurrent	-	-	-	-	-	0	0	0	0	3	3	3	3
Long Term Accounts Notes And Loans Receivable Net …	-	-	-	-	-	-	-	-	-	-	-	-	0
Notes And Loans Receivable Net Noncurrent	-	0	0	0	-	-	0	-	0	0	0	-	0
Other Assets Noncurrent	1	1	1	1	2	1	1	1	1	0	0	0	0
Operating Lease Right Of Use Asset	34	25	23	20	18	20	15	14	9	4	4	4	3
Deferred Income Tax Assets Net	2	0	-	0	-	-	-	-	-	-	-	-	0
Assets	358	371	369	323	323	330	318	318	285	195	183	181	71
Liabilities And Stockhold…
Accounts Payable Current	13	12	12	4	11	6	3	3	3	1	2	2	4
Accounts Payable Related Parties Current	-	0	0	0	0	0	0	0	0	0	0	0	0
Accrued Liabilities Current	8	9	6	10	7	9	9	15	6	12	10	8	3
Derivative Liabilities Current	1	2	7	8	17	7	12	48	35	0	0	2	1
Notes Payable Related Parties Classified Current	-	-	-	-	-	-	0	0	0	0	0	0	5
Liabilities Current
Deferred Revenue Current	-	-	-	-	-	-	-	-	0	0	0	0	0
Liabilities Current	55	50	50	42	47	30	29	70	45	14	13	13	12
Operating Lease Liability Current	5	5	4	4	3	3	4	-	-	-	-	-	-
Long Term Debt Current	4	4	7	3	2	2	-	-	-	-	-	-	-
Accrued Income Taxes Current	25	18	14	13	7	4	1	3	2	1	-	-	0
Accrued Payroll Taxes Current	-	-	-	-	-	-	-	-	-	-	-	-	0
Long Term Debt Noncurrent	153	151	149	128	126	123	121	118	97	59	54	54	14
Liabilities Noncurrent
Liabilities Noncurrent	183	174	171	147	143	141	133	132	106	63	58	59	17
Operating Lease Liability Noncurrent	30	24	22	19	17	18	12	14	9	4	4	4	3
Deferred Income Tax Liabilities Net	-	-	0	-	1	-	-	-	-	-	-	-	-
Liabilities	239	225	221	189	191	171	161	202	151	77	71	72	29
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Stockholders Equity	119	146	148	134	132	160	157	121	134	118	112	109	42
Commitments And Contingencies	-	-	-	-	-	-	-	-	-	-	-	-	0
Additional Paid In Capital	202	199	201	181	180	180	180	172	163	165	159	158	85
Retained Earnings Accumulated Deficit	-81	-51	-51	-44	-46	-19	-21	-55	-28	-46	-45	-47	-42
Treasury Stock Value	-2	-2	-2	-2	-2	-2	-2	-2	-2	-2	-2	-1	-1
Liabilities And Stockholders Equity	358	371	369	323	323	330	318	318	285	195	183	181	71
Marketable Securities Unrealized Gain Loss	0	0	0	0	0	0	0	0	0	0	0	-	-0
Accumulated Depreciation Depletion And Amortizatio…	9	8	7	6	5	4	3	2	2	2	1	1	1
Finite Lived Intangible Assets Accumulated Amortiz…	33	29	25	21	16	14	12	10	8	7	5	2	0
Marketable Securities Gain Loss	-	-	-	-	-	-	-	-	-	-	-	0	0
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	-	0	0	-	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	-	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	250	250	250	250	250	250	250	250	250	250	250	250	250
Common Stock Shares Issued	75	73	72	56	56	56	56	53	45	45	43	43	43
Shares Outstanding	74	73	71	55	55	55	54	53	45	44	42	42	42
Treasury Stock Common Shares	1	1	1	1	1	1	1	1	1	1	1	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2023	-3.74%	0.93%	-15.90%	12.93%	7.62%	-15.65%	-3.33%	25.00%	75.50%	-22.73%	-41.99%	-52.84%
2022	-21.14%	-39.43%	-44.57%	24.75%	0.99%	23.76%	56.52%	23.10%	29.13%	-8.42%	-11.02%	-14.41%
2021	-1.60%	-6.20%	-9.00%	-4.33%	-13.90%	-8.88%	-6.76%	-20.27%	-31.98%	-9.57%	-32.06%	-37.80%
2020	-	-	-	-	-	-	-	-	-	6.58%	14.47%	6.58%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31
Liquidity Ratios
Current Ratio	0.97	1.28	1.34	1.77	1.51	2.38	2.34	1.02	2.75	2.72	2.71	2.41	0.49
Quick Ratio	0.43	0.50	0.53	0.96	0.93	1.48	1.39	0.74	2.45	1.77	1.87	1.93	0.22
Working Capital	-1.79M	13.99M	16.76M	32.15M	24.35M	41.55M	38.25M	1.10M	79.14M	24.01M	22.44M	18.46M	-6.36M
Leverage & Debt
Debt to Equity	2.00	1.54	1.49	1.41	1.44	1.07	1.02	1.67	1.13	0.65	0.64	0.66	0.69
Interest Coverage TTM	0.10	0.55	0.62	0.76	0.43	0.74	0.61	0.53	1.48	-0.44	-3.42	-18.93	-145.13
Debt Ratio	0.67	0.61	0.60	0.59	0.59	0.52	0.51	0.64	0.53	0.40	0.39	0.40	0.41
Efficiency & Turnover
Asset Turnover TTM	0.51	0.48	0.48	0.52	0.52	0.56	0.54	0.48	0.61	0.79	0.60	0.38	0.47
Days Sales Outstanding TTM	9.24	11.03	13.14	9.57	9.55	10.90	12.17	9.91	8.65	8.82	12.54	13.08	12.04
Receivables Turnover TTM	39.49	33.11	27.77	38.15	38.23	33.48	30.00	36.84	42.21	41.38	29.11	27.90	30.31
Per Share Metrics
Diluted EPS TTM	-0.66	-0.48	-0.63	0.02	-0.49	0.19	0.19	-0.09	0.19	-0.15	-0.20	-	-0.47
Free Cash Flow Per Share TTM	0.07	0.10	0.15	-0.22	-0.14	-0.24	-0.34	0.06	0.06	-0.06	-0.15	-0.17	-0.27
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.04	0.10	0.13	0.13	0.09	0.02	0.00
Margin Metrics
Gross Profit Margin TTM	44.09%	53.59%	55.36%	55.12%	50.38%	48.52%	47.10%	43.88%	45.52%	42.11%	39.05%	32.32%	28.23%
Operating Profit Margin TTM	1.91%	10.06%	11.60%	13.90%	8.07%	13.02%	8.70%	5.88%	9.60%	-2.26%	-14.50%	-50.52%	-95.43%
Net Profit Margin TTM	-24.76%	-24.74%	-23.05%	1.34%	-16.48%	17.91%	18.79%	-3.49%	17.45%	-7.61%	-16.38%	-54.03%	-80.90%
Growth Metrics
Net Revenue Growth (1Y)	8.20%	16.14%	23.31%	38.68%	47.00%	62.22%	105.36%	201.11%	351.73%	364.12%	279.00%	195.12%	93.54%
Net Income Growth (1Y)	62.56%	-260.45%	-251.22%	-153.48%	-238.88%	-481.64%	-335.58%	-80.57%	-197.42%	-52.19%	-18.88%	40.43%	14.38%
EPS Growth (1Y)	35.11%	-194.27%	-222.85%	-144.87%	-212.22%	-428.85%	-302.78%	-82.32%	-192.65%	-54.30%	-19.14%	31.65%	-6.37%
Valuation Metrics
P/E TTM	-0.92	-1.65	-1.71	28.06	-2.89	2.00	2.23	-23.23	4.06	-11.49	-9.46	-4.48	-3.16
P/B TTM	0.33	0.47	0.44	0.47	0.57	0.33	0.36	0.81	0.58	0.67	0.91	0.89	1.47
P/S TTM	0.23	0.41	0.39	0.38	0.48	0.36	0.42	0.81	0.71	0.87	1.55	2.42	2.56
Market Cap	39.35M	68.98M	65.38M	63.23M	75.93M	52.26M	56.31M	97.90M	76.88M	78.58M	101.39M	97.17M	61.41M
Enterprise Value	176.91M	204.48M	200.95M	159.25M	164.76M	137.92M	143.53M	168.08M	133.23M	116.66M	134.50M	128.45M	74.08M
Calculated Values
Free Cash Flow TTM	4.34M	8.95M	8.93M	-12.09M	-7.31M	-12.47M	-16.58M	2.67M	2.76M	-2.76M	-6.14M	-7.14M	-10.98M
Net Debt	137.56M	135.50M	135.57M	96.02M	88.82M	85.66M	87.22M	70.18M	56.34M	38.08M	33.12M	31.29M	12.67M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2024-04-11Purchase

Owner: Pabon, Daniel

Title: Chief Regulatory Officer

Shares: 150

Price/Share: $0.70

Value: $105.00

Shares Owned: 150

Relationship: Officer

Ownership: Direct

2023-12-29Purchase

Owner: Garwood, Jeff

Title: -

Shares: 15,158

Price/Share: $0.00

Value: -

Shares Owned: 490,093

Relationship: Director

Ownership: Direct

2023-12-05Purchase

Owner: Jones, Christine

Title: Chief Legal Officer

Shares: 1,880

Price/Share: $0.56

Value: $1,052.80

Shares Owned: 4,355

Relationship: Officer

Ownership: Direct

2023-11-29Purchase

Owner: Hoffmaster, Forrest

Title: Chief Financial Officer

Shares: 9,088

Price/Share: $0.58

Value: $5,271.04

Shares Owned: 25,000

Relationship: Officer

Ownership: Direct

2023-11-29Purchase

Owner: Krishnamurthy, Nirup

Title: Chief Executive Officer

Shares: 6,600

Price/Share: $0.59

Value: $3,894.00

Shares Owned: 1,616,600

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2024-04-11	Pabon, Daniel	Officer	Chief Regulatory Officer	Direct	Purchase	150	0.70	$105.00	150	4
2023-12-29	Garwood, Jeff	Director	-	Direct	Purchase	15,158	0.00	$0.00	490,093	4
2023-12-05	Jones, Christine	Officer	Chief Legal Officer	Direct	Purchase	1,880	0.56	$1,052.80	4,355	4
2023-11-29	Hoffmaster, Forrest	Officer	Chief Financial Officer	Direct	Purchase	9,088	0.58	$5,271.04	25,000	4
2023-11-29	Krishnamurthy, Nirup	Director,Officer	Chief Executive Officer	Direct	Purchase	6,600	0.59	$3,894.00	1,616,600	4
2023-09-29	Garwood, Jeff	Director	-	Direct	Purchase	22,152	0.00	$0.00	474,935	4
2023-08-28	Garwood, Jeff	Director	-	Direct	Purchase	50,000	0.64	$32,000.00	452,783	4
2023-02-13	Dye, Justin	Director,TenPercentOwner	-	Indirect	Purchase	500,000	1.50	$750,000.00	500,000	4/A
2023-02-13	Dye, Justin	Director,Officer,TenPercentOwner	CEO	Indirect	Purchase	500,000	1.50	$750,000.00	1,868,062	4
2022-08-22	Garwood, Jeff	Director	-	Direct	Purchase	5,840	1.37	$8,000.80	273,657	4
2022-08-19	Garwood, Jeff	Director	-	Direct	Purchase	2,059	1.43	$2,944.37	267,817	4
2022-04-19	Garwood, Jeff	Director	-	Direct	Purchase	19,304	1.82	$35,133.28	192,735	4
2022-04-13	Garwood, Jeff	Director	-	Direct	Purchase	8,000	2.06	$16,480.00	160,735	4
2022-04-12	Garwood, Jeff	Director	-	Direct	Purchase	10,000	2.10	$21,000.00	152,735	4
2022-04-11	Garwood, Jeff	Director	-	Direct	Purchase	15,000	2.11	$31,650.00	142,735	4
2022-04-08	Garwood, Jeff	Director	-	Direct	Purchase	13,500	2.05	$27,675.00	127,735	4
2022-04-06	Garwood, Jeff	Director	-	Direct	Purchase	5,000	2.08	$10,400.00	112,735	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2024-03-31

0.44%

Inst. Shares: 281,734

Shares Outstanding: 64,535,245

2023-12-31

0.48%

Inst. Shares: 306,724

Shares Outstanding: 64,535,245

2023-09-30

0.35%

Inst. Shares: 306,734

Shares Outstanding: 87,202,537

2023-06-30

0.51%

Inst. Shares: 306,734

Shares Outstanding: 60,538,317

2023-03-31

0.56%

Inst. Shares: 314,034

Shares Outstanding: 55,835,501

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2024-03-31	281,734	64,535,245	0.44%
2023-12-31	306,724	64,535,245	0.48%
2023-09-30	306,734	87,202,537	0.35%
2023-06-30	306,734	60,538,317	0.51%
2023-03-31	314,034	55,835,501	0.56%
2022-12-31	306,724	53,637,003	0.57%
2022-09-30	320,724	51,232,943	0.63%
2022-06-30	323,024	49,178,494	0.66%
2022-03-31	323,024	46,841,971	0.69%
2021-12-31	337,524	43,339,092	0.78%
2021-09-30	335,624	44,145,709	0.76%
2021-06-30	340,945	42,332,144	0.81%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Medicine Man Technologies, Inc. (SHWZ) — SEC Financial Statements & Analysis

Medicine Man Technologies, Inc. (SHWZ) is a services-management consulting services company, incorporated in NV. Medicine Man Technologies, Inc. trades on OTC as: SHWZ. Based on its latest SEC filing (Form 10-Q, period ending 2023-12-31), Medicine Man Technologies, Inc. reported a 8.20% year-over-year revenue growth, a Gross Profit Margin of 44.09% (TTM), a Debt-to-Equity ratio of 2.00x, a Price-to-Sales (P/S) ratio of 0.23x (TTM), a Price-to-Book (P/B) ratio of 0.33x (TTM), at a market cap of $39.35M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 8.20%
Gross Profit Margin TTM: 44.09%
Debt To Equity: 2.00x
P/S TTM: 0.23x
P/B TTM: 0.33x
Market Cap: $39.35M

Data as of 2023-12-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Medicine Man Technologies, Inc. in?

Medicine Man Technologies, Inc. (SHWZ) operates in the Services-Management Consulting Services industry.

What is SHWZ's market cap?

Medicine Man Technologies, Inc. (SHWZ) has a market capitalization of $39.35M as of 2023-12-31.

What exchange does SHWZ trade on?

Medicine Man Technologies, Inc. (SHWZ) trades on the OTC.

Where is Medicine Man Technologies, Inc. incorporated?

Medicine Man Technologies, Inc. is incorporated in NV.